Pieris AG
Records under this name other than patents Pieris AG holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,892,827 | Compound with Affinity for the Cytotoxic T Lymphocyte-Associated Antigen (CTLA-4) Formerly held In force · High confidence | In force | High confidence | |
| US 9,221,887 | Muteins of Tear Lipocalin and Methods for Obtaining the Same Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 8,313,924 | Muteins of Tear Lipocalin and Methods for Obtaining the Same Formerly held In force · High confidence | In force | High confidence | |
| US 9,549,968 | Muteins of Human Lipocalin 2 (LCNC,HNGAL) with Affinity for a Given Target Formerly held In force · High confidence | In force | High confidence | |
| US 10,618,941 | Muteins of Human Lipocalin 2 (LCN2,HNGAL) with Affinity for a Given Target Formerly held In force · High confidence | In force | High confidence | |
| US 8,986,951 | Tear Lipocalin in Muteins Binding IL-4 R Alpha Formerly held In force · High confidence | In force | High confidence | |
| US 10,232,014 | Tear Lipocalin Muteins Binding IL-4 R Alpha Formerly held In force · Low confidence | In force | Low confidence | |
| US 11,827,681 | Muteins of Human Lipocalin 2 (LCN2,HNGAL) with Affinity for a Given Target Formerly held In force · High confidence | In force | High confidence | |
| US 8,987,415 | Recombinant Bacterial Lipocalin BLC and Uses Thereof Formerly held In force · High confidence | In force | High confidence | |
| US 9,260,492 | Muteins of Human Lipocalin 2 with Affinity for GLYPICAN-3 (GPC-3) Formerly held In force · High confidence | In force | High confidence |